Oxidase.

Diamine oxidase is a copper containing amine oxidase; the copper ion at the active site is part of the catalytic cycle that oxidises histamine and other diamines. Adequate copper status is a requirement for the body's own DAO activity in gut mucosa and kidney. This does not mean extra copper raises activity in someone already replete.

Pyridoxal phosphate is the working cofactor across amine metabolising enzymes, and B6 status is a standard consideration in histamine handling protocols alongside DAO. The link is nutritional adequacy rather than a dose response with the enzyme supplement itself. Low B6 status is worth correcting before concluding an enzyme did nothing.

Ascorbate participates in histamine degradation independently of the diamine oxidase route and is commonly stacked with DAO for that reason. The two act by different chemistry on the same substrate pool, which is what additive means here. The size of the ascorbate contribution in normal dietary intakes is not well quantified.

Quercetin is used for its mast cell stabilising activity, which limits histamine release, while DAO acts on histamine already present in the gut lumen. Upstream and downstream of the same molecule, so the pairing is coherent. Most of the mast cell work is cell based, so this is mechanism rather than clinical demonstration.

Diamine oxidase is a protein and loses activity under strong gastric acid and pepsin exposure, which is why DAO capsules are usually enteric protected. Deliberately acidifying the stomach at the same moment works against that protection. If both are being used, separating them in time is the sensible move.

Pepsin hydrolyses dietary protein, and a supplemental enzyme is dietary protein as far as pepsin is concerned. Co-dosing a protease with an intact enzyme supplement shortens the window in which the enzyme is still active. Enteric coating exists precisely to keep the two apart.

Some lactic acid bacteria carry histidine decarboxylase and generate histamine, while others do not and some degrade it. A probiotic can therefore work with or against a histamine degrading enzyme depending entirely on the strain, not the genus. Strain level identification on the label is the only way to tell which situation applies.

Broad spectrum protease blends will degrade a co-formulated diamine oxidase in the capsule environment and in the gut. Manufacturers who combine them normally separate the two into different beads or coatings. A single blended powder holding both is a formulation red flag worth asking about.

Glucose oxidase converts glucose and oxygen into gluconic acid and hydrogen peroxide, and catalase breaks that peroxide down to water and oxygen. The two are paired routinely in food and feed applications to control the peroxide load. Without the second enzyme the peroxide is the point rather than a by-product, which is the intent in antimicrobial uses.

Glucose oxidase and the monoamine oxidase family are flavoproteins carrying FAD at the active site, and FAD is built from riboflavin. Riboflavin status therefore underpins the body's own flavin dependent oxidase capacity. For a supplemental fungal enzyme the FAD is already bound, so this point concerns endogenous enzymes.

Xanthine oxidase and aldehyde oxidase both depend on a molybdenum cofactor at the catalytic centre. Molybdenum adequacy is what allows those endogenous oxidases to function at all. Intakes needed are small and deficiency is uncommon on an ordinary diet.

Several oxidase and oxygenase enzymes carry heme or non-heme iron centres that perform the electron transfer step. Iron status therefore sits underneath a broad slice of oxidative enzyme capacity. This is a background adequacy relationship, not a reason to combine iron with an enzyme supplement.